Mar 5, 2015

Update: Pharmaceutical pricing

An article in this month's Chemical & Engineering News (unfortunately, the link is only available to subscribers) suggested that innovative pricing models might lead the way towards cheaper drug pricing in the US. Pharmaceutical benefits managers are now amortizing the costs of treating select illnesses, rather than pay per pill. This new pricing plan would cut costs over time, particularly for long-term illnesses, such as Hepatitis C, where costs may exceed $1,000 per pill.

This post is an update to: The high price of prescription drugs